Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1624
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley